Feldan Therapeutics' Series A - II Round

Feldan Therapeutics raised a round of funding on September 18, 2018.

Feldan Therapeutics is a Recombinant Protein Company engaged in the discovery, development, manufacturing and marketing of Research, Therapeutic and Industrial protein products and services. The compa…

Articles about Feldan Therapeutics' Series A - II Round: